Your browser doesn't support javascript.
loading
Prevalence of BRCA mutation in breast and ovarian cancer among women in India: A systematic review and meta-analysis protocol.
Patra, Abhilash; Ali, Syeda Sana; Devi, Ng Marina; Qadeer, Amatullah Sana; Kamalakannan, Sureshkumar; Nag, Shona; Kulkarni, Shriniwas Subhash; Rajappa, Senthil; Hariharan, Nisha; Pant, Hira Ballabh; Agiwal, Varun; A Y, Nirupama.
Afiliação
  • Patra A; E2E Pfizer Fellow, Indian Institute of Public Health, Hyderabad, Telangana, India.
  • Ali SS; E2E Pfizer Fellow, Indian Institute of Public Health, Hyderabad, Telangana, India.
  • Devi NM; Indian Institute of Public Health, Hyderabad, Telangana, India.
  • Qadeer AS; Indian Institute of Public Health, Hyderabad, Telangana, India.
  • Kamalakannan S; Department of Social Work, Education and Community Wellbeing, Northumbria University, London, United Kingdom.
  • Nag S; Oncology Department, Sahyadri Group of Hospitals, Pune, Maharashtra, India.
  • Kulkarni SS; Oncology Department, Sahyadri Group of Hospitals, Pune, Maharashtra, India.
  • Rajappa S; Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, India.
  • Hariharan N; Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, India.
  • Pant HB; Indian Institute of Public Health, Hyderabad, Telangana, India.
  • Agiwal V; Indian Institute of Public Health, Hyderabad, Telangana, India.
  • A Y N; Indian Institute of Public Health, Hyderabad, Telangana, India.
PLoS One ; 19(7): e0306612, 2024.
Article em En | MEDLINE | ID: mdl-39012888
ABSTRACT

PURPOSE:

We present a methodically devised protocol for conducting a systematic review and meta-analysis aimed at ascertaining the prevalence of BReast CAncer gene (BRCA) mutations in breast and ovarian cancer (BOC) among women in India. The review will include cross-sectional, cohort, case-series, and registry-based studies focusing on females clinically diagnosed with any stage of BOC, tested for BRCA germline mutation and undergone any form of treatment.

METHODS:

A Cochrane literature search will be carried out to identify all the published and unpublished articles available in English from 2010 till date across various electronic databases including PubMed, Psych Info, SCI, Cochrane Central, Embase, Scopus, IND Med and Google Scholar. A step-by-step process will be followed to select all the relevant studies for final inclusion using Rayyan software. The selection process of the review will be reported based on Preferred Reporting Items for Systematic Review and Meta-analysis Protocols (PRISMA) checklist. The protocol has been registered in PROSPERO (ID CRD42023463452). Joanna Briggs Institute Critical Appraisal Checklist will be used to evaluate the methodological quality of the included studies. The outcome measure will be the prevalence of BRCA1/2 gene mutation in this population. Meta-analysis will be performed to report the pooled prevalence along with 95% confidence interval.

DISCUSSION:

The results of this review study will provide valuable insights for clinicians, and policy makers, enabling them to formulate guidelines that underscore the importance of screening for BRCA mutations in cases of BOC.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Revisões Sistemáticas como Assunto Limite: Female / Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Revisões Sistemáticas como Assunto Limite: Female / Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article